Target intelligence / Profile preview

23S ribosomal RNA (peptidyl transferase center) (23S rRNA PTC)

Target
23S rRNA PTC
Molecular classification
Ribosomal RNA, Ribozyme
01

Overview

The 23S ribosomal RNA (rRNA) is the central catalytic component of the large (50S) subunit of the bacterial ribosome, acting as a ribozyme to facilitate protein synthesis (Polacek & Mankin, 2005). Within this molecule, the peptidyl transferase center (PTC) is the specific site where peptide bond formation occurs between the aminoacyl-tRNA and the peptidyl-tRNA (Nissen et al., 2000). Because of its fundamental role in bacterial survival, the PTC is a major target for several classes of antibiotics, including macrolides, oxazolidinones, lincosamides, and pleuromutilins (Wilson, 2014). These drugs typically bind to the PTC or the adjacent nascent peptide exit tunnel, physically preventing the elongation of the protein chain (Dunkle et al., 2010). Resistance to these agents frequently arises through point mutations in the 23S rRNA or through enzymatic modifications, such as methylation by Erm or Cfr enzymes, which alter the drug-binding pocket (Vester & Douthwaite, 2001). Furthermore, the structural similarity between bacterial 23S rRNA and human mitochondrial rRNA can lead to off-target effects, such as mitochondrial toxicity and myelosuppression, which are key considerations in the clinical use of these antibiotics (Leach et al., 2007).

Other names
23S ribosomal RNAPeptidyl transferase centerPTC50S ribosomal RNALarge subunit ribosomal RNARibozyme
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the peptidyl transferase center (PTC) of the 23S rRNA, which either directly blocks peptide bond formation or sterically obstructs the nascent peptide exit tunnel (Wilson, 2014; Dunkle et al., 2010).

03

Biological functions

Protein synthesisPeptide bond formationTranslation elongation
04

Disease associations

Infection
05

Safety considerations

Mitochondrial protein synthesis inhibitionMyelosuppressionDevelopment of multi-drug resistanceSerotonin syndrome (due to MAO inhibition by certain oxazolidinones)
06

Interacting drugs

Chloramphenicol

12 more in the full profile.

07

Biomarkers

23S rRNA A2058G mutation23S rRNA A2059G mutation23S rRNA G2576T mutationCfr methyltransferase expressionErm methylase expression

Beyond the preview

Go deeper on 23S ribosomal RNA (peptidyl transferase center) (23S rRNA PTC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA (peptidyl transferase center) (23S rRNA PTC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call